Book contents
- Office Gynecology
- Office Gynecology
- Copyright page
- Contents
- Contributors
- Preface
- Section I Pelvic Pain
- Section II Vaginal Discharge and Sexually Transmitted Infections
- Section III Amenorrhea and Abnormal Vaginal Bleeding
- Section IV Contraception and Abortion
- Section V Breast Problems
- Section VI Cancer Screening and Prevention
- Case 38 A 22-Year-Old Woman with LSIL on Initial Cervical Cytology
- Case 39 A 25-Year-Old Woman Who Has Received a Letter from an Aunt Recommending Lynch Testing (Cascade Testing)
- Case 40 A 30-Year-Old Woman with Positive Margins on LEEP for HSIL
- Case 41 A 32-Year-Old Woman Whose Paternal Aunt and Grandmother Had Ovarian Cancer
- Case 42 A 23-Year-Old Woman with HSIL on Cervical Cytology
- Case 43 A 35-Year-Old Woman with a Strong Family History of Breast Cancer Not Linked to BRCA Mutation
- Case 44 A 25-Year-Old Woman with LSIL Desiring HPV Vaccination
- Section VII Vulvar Disease
- Section VIII Infertility
- Section IX Preconception Planning
- Section X Pediatric and Adolescent Problems
- Section XI Pelvic Masses and Cysts
- Section XII Incontinence and Prolapse
- Section XIII Behavioral, Sexual, and Social Health
- Section XIV Managing and Aging
- Index
- References
Case 41 - A 32-Year-Old Woman Whose Paternal Aunt and Grandmother Had Ovarian Cancer
from Section VI - Cancer Screening and Prevention
Published online by Cambridge University Press: 20 February 2019
Book contents
- Office Gynecology
- Office Gynecology
- Copyright page
- Contents
- Contributors
- Preface
- Section I Pelvic Pain
- Section II Vaginal Discharge and Sexually Transmitted Infections
- Section III Amenorrhea and Abnormal Vaginal Bleeding
- Section IV Contraception and Abortion
- Section V Breast Problems
- Section VI Cancer Screening and Prevention
- Case 38 A 22-Year-Old Woman with LSIL on Initial Cervical Cytology
- Case 39 A 25-Year-Old Woman Who Has Received a Letter from an Aunt Recommending Lynch Testing (Cascade Testing)
- Case 40 A 30-Year-Old Woman with Positive Margins on LEEP for HSIL
- Case 41 A 32-Year-Old Woman Whose Paternal Aunt and Grandmother Had Ovarian Cancer
- Case 42 A 23-Year-Old Woman with HSIL on Cervical Cytology
- Case 43 A 35-Year-Old Woman with a Strong Family History of Breast Cancer Not Linked to BRCA Mutation
- Case 44 A 25-Year-Old Woman with LSIL Desiring HPV Vaccination
- Section VII Vulvar Disease
- Section VIII Infertility
- Section IX Preconception Planning
- Section X Pediatric and Adolescent Problems
- Section XI Pelvic Masses and Cysts
- Section XII Incontinence and Prolapse
- Section XIII Behavioral, Sexual, and Social Health
- Section XIV Managing and Aging
- Index
- References
- Type
- Chapter
- Information
- Office GynecologyA Case-Based Approach, pp. 125 - 128Publisher: Cambridge University PressPrint publication year: 2019
References
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Genetic/familial high-risk assessment: breast and ovarian. Version 2.2017. 2016. www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. (Accessed April 27, 2017).Google Scholar
Moyer VA, Force USPST. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:271–281.Google Scholar
Couch, FJ, Nathanson, KL, Offit, K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 2014;343:1466.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists, ACOG Committee on Practice Bulletins–Gynecology, ACOG Committee on Genetics, Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol 2009;113: 957–66 (reaffirmed 2015).Google Scholar
Lancaster, JM, Powell, CB, Chen, LM, Richardson, DL, SGO Clinical Practice Committee. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 2015;136:3–7.CrossRefGoogle ScholarPubMed
King, MC, Wieand, S, Hale, K et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001;286:2251–2256.Google Scholar
Moorman, PG, Havrilesky, LJ, Gierisch, JM et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol 2013;31:4188–4198.CrossRefGoogle ScholarPubMed
Society of Gynecologic Oncology. SGO clinical practice statement: salpingectomy for ovarian cancer prevention. 2013. www.sgo.org/clinical-practice/guidelines/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention/. (Accessed February 18, 2015).Google Scholar
Domchek, SM, Friebel, TM, Singer, CF et al. Association of risk-reducingsurgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967–975.Google Scholar
Rebbeck, TR, Friebel, T, Wagner, T et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2005;23:7804–7810.Google Scholar